Figure 4

Distribution of inhibition zone diameters for different genotypes for (A) imipenem, (B) cefotaxime, (C) cefoxitin, (D) ciproflocaxin, and (E) gentamicin antimicrobials.

Distribution of inhibition zone diameters for different genotypes for (A) imipenem, (B) cefotaxime, (C) cefoxitin, (D) ciproflocaxin, and (E) gentamicin antimicrobials.